Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$168.19 - $186.01 $1.35 Million - $1.49 Million
-8,000 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $323,000 - $358,940
-2,000 Reduced 20.0%
8,000 $1.29 Million
Q2 2021

Aug 11, 2021

SELL
$159.48 - $171.07 $637,920 - $684,280
-4,000 Reduced 28.57%
10,000 $1.65 Million
Q1 2021

May 13, 2021

SELL
$153.07 - $170.48 $29.9 Million - $33.3 Million
-195,500 Reduced 93.32%
14,000 $2.3 Million
Q4 2020

Feb 10, 2021

SELL
$137.11 - $157.38 $24.1 Million - $27.7 Million
-176,000 Reduced 45.65%
209,500 $33 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $19.4 Million - $21.3 Million
-138,500 Reduced 26.43%
385,500 $57.4 Million
Q2 2020

Aug 12, 2020

SELL
$128.81 - $155.51 $42 Million - $50.7 Million
-326,000 Reduced 38.35%
524,000 $73.7 Million
Q1 2020

May 13, 2020

BUY
$111.14 - $153.99 $44.8 Million - $62.1 Million
403,500 Added 90.37%
850,000 $111 Million
Q4 2019

Feb 11, 2020

BUY
$127.5 - $146.44 $55.1 Million - $63.3 Million
432,500 Added 3089.29%
446,500 $65.1 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $942,900 - $1.05 Million
7,500 Added 115.38%
14,000 $1.96 Million
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $75.6 Million - $91 Million
-615,500 Reduced 98.95%
6,500 $839,000
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $53.7 Million - $63.2 Million
-442,000 Reduced 41.54%
622,000 $85.9 Million
Q2 2018

Aug 10, 2018

BUY
$119.4 - $131.76 $90 Million - $99.3 Million
754,000 Added 243.23%
1,064,000 $129 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $38.8 Million - $45.9 Million
310,000 New
310,000 $39.7 Million
Q4 2017

Feb 12, 2018

SELL
$131.22 - $143.62 $38.6 Million - $42.2 Million
-293,900 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $38.1 Million - $39.8 Million
293,900
293,900 $38.2 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $378B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Holowesko Partners Ltd. Portfolio

Follow Holowesko Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Holowesko Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Holowesko Partners Ltd. with notifications on news.